참고문헌 (38)

1. Chandan RC. 1999. Enhancing market value of milk by adding cultures. J. Dairy Sci. 82: 2245-2256. 

   상세보기

2. Gill H, Prasad J. 2008. Probiotics, immunomodulation, and health benefits. Adv. Exp. Med. Biol. 606: 423-454. 

   

3. Francoise L. 2010. Occurrence and role of lactic acid bacteria in seafood products. Food Microbiol. 27: 698-709. 

   상세보기

4. Chamba JF, Irlinger F. 2004. Secondary and adjunct cultures. pp. 191-206. In Patrick FF, Paul LHM, Timothy MC, Timothy PG (eds.), Cheese: chemistry, physics and microbiology, 3rd Ed. Elsevier Academic Press, London. 

5. Alander M, Satokari R, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, et al. 1999. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl. Environ. Microbiol. 65: 351-354. 

   상세보기

6. Danielsen M, Wind A. 2003. Susceptibility of Lactobacillus spp. to antimicrobial agents. Int. J. Food Microbiol. 82: 1-11. 

   상세보기

7. Kirjavainen PV, Ouwehand AC, Isolauri E, Salminen SJ. 1998. The ability of probiotic bacteria to bind to human intestinal mucus. FEMS Microbiol. Lett. 167: 185-189. 

   상세보기

8. Kos BVZE, Suskovic J, Vukovic S, Simpraga M, Frece J, Matosic S. 2003. Adhesion and aggregation ability of probiotic strain Lactobacillus acidophilus M92. J. Appl. Microbiol. 94: 981-987. 

   상세보기

9. Tannock GW. 1999. Probiotics: a critical review. J. Antimicrob. Chemother. 43: 849. 

10. Abriouel H, Casado Munoz MC, Lerma LL, Montoro BP, Bokelmann W, Pichner R, et al. 2015. New insights in antibiotic resistance of Lactobacillus species from fermented foods. Food Res. Int. 78: 465-481. 

    상세보기

11. Donohue DC, Salminen S. 1996. Safety of probiotic bacteria. Asia pacific J. Clin. Nutr. 5: 25-28. 

12. Saxelin M, Rautelin H, Salminen S, Makela PH. 1996. Safety of commercial products with viable Lactobacillus strains. Infect. Dis. Clin. Pract. 5: 331-335. 

    상세보기

13. Antony SJ. 2000. Lactobacillemia: an emerging cause of infection in both the immunocompromised and the immunocompetent host. J. Natl. Med. Assoc. 92: 83-86. 

    상세보기

14. Schlegel L, Lemerle S, Geslin P. 1998. Lactobacillus species as opportunistic pathogens in immunocompromised patients. Eur. J. Clin. Microbiol. Infect. Dis. 17: 887-888. 

    상세보기

15. Vijayalakshmi S, Adeyemi DE, Choi IY, Sultan G, Madar IH, Park MK. 2020. Comprehensive in silico analysis of lactic acid bacteria for the selection of desirable probiotics. LWT 130: 109617. 

    상세보기

16. Chen L, Yang J, Yu J, Yao Z, Sun L, Shen Y, et al. 2005. VFDB: a reference database for bacterial virulence factors. Nucl. Acids Res. 33: D325-D328. 

17. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, et al. 2012. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 67: 2640-2644. 

    상세보기

18. Arndt D, Grant JR, Marcu A, Sajed T, Pon A, Liang Y, et al. 2016. PHASTER: a better, faster version of the PHAST phage search tool. Nucl. Acids Res. 44: W16-W21. 

    상세보기

19. Priyadarshani WM, Rakshit SK. 2011. Screening selected strains of probiotic lactic acid bacteria for their ability to produce biogenic amines (histamine and tyramine). Int. J. Food Sci. Technol. 46: 2062-2069. 

    상세보기

20. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Rychen G, Aquilina G, Azimonti G, Bampidis V, Bastos MDL, et al. 2018. Guidance on the characterisation of microorganisms used as feed additives or as production organisms. EFSA J. 16: e05206. 

21. OECD. 2001. OECD Guideline for the Testing of Chemicals. No. 423: Acute Oral Toxicity - Acute Toxic Class Method, pp.14. Paris, France: Organisation for Economic Co-operation and Development. 

22. Ammor MS, Florez AB, Mayo B. 2007. Antibiotic resistance in nonenterococcal lactic acid bacteria and bifidobacteria. Food Microbiol. 24: 559-570. 

    상세보기

23. Charteris WP, Kelly PM, Morelli L, Collins JK. 2001. Gradient diffusion antibiotic susceptibility testing of potentially probiotic lactobacilli. J. Food Prot. 64: 2007-2014. 

    상세보기

24. Mayrhofer S, Van Hoek AHAM, Mair C, Huys G, Aarts HJ, Kneifel W, et al. 2010. Antibiotic susceptibility of members of the Lactobacillus acidophilus group using broth microdilution and molecular identification of their resistance determinants. Int. J. Food Microbiol. 144: 81-87. 

    상세보기

25. Temmerman R, Pot B, Huys G, Swings J. 2003. Identification and antibiotic susceptibility of bacterial isolates from probiotic products. Int. J. Food Microbiol. 81: 1-10. 

    상세보기

26. Kodner C, Kudrimoti A. 2003. Diagnosis and management of acute interstitial nephritis. Am. Fam. Physician 67: 2527-2534. 

    상세보기

27. Kim DH, Jin YH. 2001. Intestinal bacterial β-glucuronidase activity of patients with colon cancer. Arch. Pharm. Res. 24: 564-567. 

    원문보기 상세보기

28. Choi YB, Kim KS, Rhee JS. 2002. Hydrolysis of soybean isoflavone glucosides by lactic acid bacteria. Biotechnol. Lett. 24: 2113-2116. 

    상세보기

29. Delgado S, O' Sullivan E, Fitzgerald G, Mayo B. 2008. In vitro evaluation of the probiotic properties of human intestinal Bifidobacterium species and selection of new probiotic candidates. J. Appl. Microbiol. 104: 1119-1127. 

    상세보기

30. Colombo M, Castilho NP, Todorov SD, Nero LA. 2018. Beneficial properties of lactic acid bacteria naturally present in dairy production. BMC Microbiol. 18: 219. 

    상세보기

31. Spano G, Russo P, Lonvaud-Funel A, Lucas P, Alexandre H, Grandvalet C, et al. 2010. Biogenic amines in fermented foods. Eur. J. Clin. Nutr. 64: S95-S100. 

    상세보기

32. Barbieri F, Montanari C, Gardini F, Tabanelli G. 2019. Biogenic amine production by lactic acid bacteria: a review. Foods 8: 17. 

    상세보기

33. Ladero V, Calles-Enriquez M, Fernandez M, Alvarez MA. 2010. Toxicological effects of dietary biogenic amines. Curr. Nutr. Food Sci. 6: 145-156. 

    상세보기

34. Sanders ME, Akkermans LM, Haller D, Hammerman C, Heimbach JT, Hormannsperger G. 2010. Safety assessment of probiotics for human use. Gut Microbes 1: 164-185. 

    상세보기

35. Uribarri J, Oh MS, Carroll HJ. 1998. D-lactic acidosis: a review of clinical presentation, biochemical features, and pathophysiologic mechanism. Medicine 77: 73-82. 

    상세보기

36. Moller PD, Diernaes L, Sehested J, Hyldgaard-Jensen J, Skadhauge E. 1997. Absorption and fate of L-and D-lactic acid in ruminants. Physiol. A Physiol. 118: 387-388. 

37. Quigley EM, Pot B, Sanders ME. 2018. 'Brain Fogginess' and DLactic acidosis: probiotics are not the cause. Clin. Transl. Gastroenterol. 9: 187. 

    상세보기

38. Sulemankhil I, Parent M, Jones ML, Feng Z, Labbe A, Prakash S. 2012. In vitro and in vivo characterization and strain safety of Lactobacillus reuteri NCIMB 30253 for probiotic applications. Can. J. Microbiol. 58: 776-787. 

    상세보기